Jim, Satoshi,
> It should be possible to see what the crossover point is in terms of
> benefit using dbt2 and tweaking the transactions that are run, something
> I can do if there's interest. But I agree with Satoshi; if there are
> people who will benefit from this option (which doesn't hurt those who
> choose not to use it), why not put it in?
Because your predicate is still disputed? That is, we don't know that people
will benefit yet -- pgbench is a pretty useless benchmark for real
performance comparisons.
Satoshi, if you can package up a patch on current CVS, I'll throw it at DBT2.
--
Josh Berkus
Aglio Database Solutions
San Francisco